Effective October 1, 2026, the University of Miami is implementing a streamlined submission and review process for industry-funded clinical research projects, including industry-sponsored clinical trials.
Under the new process, the IBIS Agreement record will serve as the primary administrative record, eliminating the need for a separate Funding Proposal (FP) submission.
If you are submitting an Amendment to an Industry Sponsored CTA (or SA) for an ongoing project, please submit the amendment to that agreement type following a similar process:
Note:
*ORA will be transitioning these ongoing CTA’s and SA’s into the new agreement type (ICRA) once the new agreement is available to allow for consistent tracking.
The resources below provide an overview of the new workflow, submission requirements, key responsibilities, and step-by-step guidance for departments and study teams. Please review these materials before submitting a new industry-funded clinical research project.
If you have any questions regarding the Budget/MCA Process, please contact the Clinical Trial Activation Team (CTAT), EDRO at CTATBudget@med.miami.edu.
Copyright: 2026 University of Miami. All Rights Reserved.
Emergency Information
Privacy Statement & Legal Notices
Individuals with disabilities who experience any technology-based barriers accessing University websites can submit details to our online form.